"21 new radiology facilities have been set up for FerriScan imaging since the start of 2014" AND "We anticipate the immediate use of HepaFat-Scan will be in a clinical trial in Australia and soon thereafter in the United States" AND "The company has received positive feedback from a number of clinicians that see value in the role of HepaFat-Scan in the management of their patients".
It surprises me that such a positive announcement has not led to any discussion here whatsoever. Perhaps people have been put off by the fact that the Hepafat clinical trial in Australia and the subsequent trial(s) in the USA are not yet signed contracts. However, I don't think the company would make a statement like this unless a contract was extremely likely and close to finalisation. They would also have wanted it to help the CR, I expect.
It will be interesting to see what happens when the market opens in about half an hour.
"21 new radiology facilities have been set up for FerriScan...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
